We observed that the percentages of NKG2A+CD57- NK cells were significant increase in patients with ALL when compared to healthy controls, whereas a significant decreased in the percentages of NKG2A-CD57+ NK cells was also observed. This evidence concerns the gene KLRC1 and acute lymphoblastic leukemia.